Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Empire Co. Ltd A

Start price
Target price
Perf. (%)
€24.20
20.04.23
€22.00
20.07.23
-0.83%
02.06.23

buy
Clearside Biomedical Inc

Start price
Target price
Perf. (%)
€0.98
20.04.23
€3.65
20.04.24
22.05%
21.04.24

buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€4.61
20.04.23
€8.20
20.04.24
81.37%
21.04.24

buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€2.04
20.04.23
€14.57
20.04.24
15.23%
21.04.24

buy
Clearside Biomedical Inc

Start price
Target price
Perf. (%)
€0.98
20.04.23
€5.46
20.04.24
22.05%
21.04.24

buy
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.74
20.04.23
€14.57
20.04.24
-44.59%
21.04.24

buy
Senestech Inc.

Start price
Target price
Perf. (%)
€1.40
19.04.23
€2.10
12.05.23
-7.14%
12.05.23

Gevo Inc.

Start price
Target price
Perf. (%)
€1.05
19.04.23
-
19.04.24
2.99%
26.11.23

Probably not worthwhile Investment
negative Cash Flow expected
Low dividend yield expected
High valuation
buy
MEDIQON Group AG

Start price
Target price
Perf. (%)
€14.30
19.04.23
-
19.04.24
45.45%
20.04.24

buy
Ci Financial Corp.

Start price
Target price
Perf. (%)
€9.00
19.04.23
-
19.04.24
24.44%
20.04.24

BELLUS Health Inc.

Start price
Target price
Perf. (%)
€13.20
18.04.23
-
18.04.24
-1.52%
27.04.23

Growths slower than the competition
Higher risks for its business
buy
Asics Corp.

Start price
Target price
Perf. (%)
€26.60
18.04.23
€27.00
18.04.24
6.77%
15.06.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Oremex Silver

Start price
Target price
Perf. (%)
€0.008
18.04.23
€0.000
18.04.24
-43.75%
18.10.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
American Lithium Corp

Start price
Target price
Perf. (%)
€2.10
18.04.23
€1.00
18.04.24
-75.19%
19.04.24

EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
negative Cash Flow expected
buy
Standard Lithium Ltd

Start price
Target price
Perf. (%)
€3.56
18.04.23
€3.00
18.04.24
-71.14%
19.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Bad rating
buy
Canadian Pacific City Kansas Ltd.

Start price
Target price
Perf. (%)
€73.00
18.04.23
-
18.04.24
8.22%
19.04.24

buy
Leap Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.36
17.04.23
€18.32
17.04.24
-19.05%
18.04.24

buy
My Size Inc

Start price
Target price
Perf. (%)
€0.25
17.04.23
€2.75
17.04.24
-
18.04.24

buy
U.S. Energy Corp.

Start price
Target price
Perf. (%)
€1.19
17.04.23
€2.75
17.04.24
-0.42%
18.04.24

buy
BP plc ADR

Start price
Target price
Perf. (%)
€37.00
17.04.23
€43.97
17.04.24
-3.24%
18.04.24

buy
Revelation Biosciences Inc.

Start price
Target price
Perf. (%)
€1.09
17.04.23
-
17.04.24
-19.27%
29.04.23

buy
Inpixon

Start price
Target price
Perf. (%)
€1.00
17.04.23
€1.00
17.04.24
-67.14%
29.04.23

Could be worthwhile Investment >10% per year
Very capable Management
Little innovation
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€1.74
16.04.23
-
16.04.24
-78.39%
17.04.24

Inuvo Inc.

Start price
Target price
Perf. (%)
€0.32
16.04.23
-
16.04.24
-5.54%
17.04.24

iBio Inc.

Start price
Target price
Perf. (%)
€0.95
16.04.23
€0.000
16.04.24
-80.74%
16.04.24

Some uniques
Significant cyclical dependencies
Little known brand
Higher risks for its business